These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Endothelial dysfunction: its pathogenic role in atherosclerosis and its reversal by ACE inhibition. Neutel JM. Postgrad Med; 2000 Oct; 108(5 Suppl):4-11. PubMed ID: 19667535 [Abstract] [Full Text] [Related]
3. [Endothelial dysfunction]. Nagy J, Csiky B, Kovács T, Wittmann I. Orv Hetil; 2001 Aug 05; 142(31):1667-72. PubMed ID: 11556260 [Abstract] [Full Text] [Related]
7. The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function. Izzo JL. Heart Dis; 2000 Apr 05; 2(5):380-3. PubMed ID: 11728286 [Abstract] [Full Text] [Related]
8. Effects of tamoxifen on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis. Kiortsis DN, Elisaf MS. Circulation; 2001 Dec 11; 104(24):E146-7. PubMed ID: 11780173 [No Abstract] [Full Text] [Related]
10. Effects of tamoxifen on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis. English KM, Pugh PJ, Channer KS. Circulation; 2001 Dec 11; 104(24):E146-7. PubMed ID: 11780174 [No Abstract] [Full Text] [Related]
13. Endothelial dysfunction in patients with noncomplicated and complicated hypertension. Goch A, Banach M, Mikhailidis DP, Rysz J, Goch JH. Clin Exp Hypertens; 2009 Feb 11; 31(1):20-30. PubMed ID: 19172456 [Abstract] [Full Text] [Related]
14. [Endothelial dysfunction--an important stage in the development of atherosclerotic vascular lesions (a review of the literature--1)]. Ivanova OV, Soboleva GN, Karpov IuA. Ter Arkh; 1997 Feb 11; 69(6):75-8. PubMed ID: 9297285 [No Abstract] [Full Text] [Related]
15. L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease. Ou J, Ou Z, Jones DW, Holzhauer S, Hatoum OA, Ackerman AW, Weihrauch DW, Gutterman DD, Guice K, Oldham KT, Hillery CA, Pritchard KA. Circulation; 2003 May 13; 107(18):2337-41. PubMed ID: 12732610 [Abstract] [Full Text] [Related]
16. Risk factors and their role in the diseases of the arterial wall. Patel ST, Kent KC. Semin Vasc Surg; 1998 Sep 13; 11(3):156-68. PubMed ID: 9763116 [Abstract] [Full Text] [Related]
17. Endothelial dysfunction and cardiovascular disease. Sherman DL, Loscalzo J. Cardiologia; 1997 Feb 13; 42(2):177-87. PubMed ID: 9090161 [No Abstract] [Full Text] [Related]
18. Clinically important factors influencing endothelial function. Vapaatalo H, Mervaala E. Med Sci Monit; 2001 Feb 13; 7(5):1075-85. PubMed ID: 11535960 [Abstract] [Full Text] [Related]
19. Endothelial function: a critical determinant in atherosclerosis? Landmesser U, Hornig B, Drexler H. Circulation; 2004 Jun 01; 109(21 Suppl 1):II27-33. PubMed ID: 15173060 [Abstract] [Full Text] [Related]
20. [Endothelial function in high risk cardiovascular patients]. Káli A, Jánosi A. Orv Hetil; 2006 Jan 22; 147(3):99-106. PubMed ID: 16515028 [Abstract] [Full Text] [Related] Page: [Next] [New Search]